Cite
HARVARD Citation
Walker, A. et al. (n.d.). Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia. Leukemia & lymphoma. 54 (9), pp. 1996-2002. [Online].